Compare INMD & FDUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INMD | FDUS |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 879.2M | 719.4M |
| IPO Year | 2019 | 2011 |
| Metric | INMD | FDUS |
|---|---|---|
| Price | $15.04 | $19.44 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | $16.75 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 857.9K | 248.3K |
| Earning Date | 02-10-2026 | 03-05-2026 |
| Dividend Yield | N/A | ★ 11.09% |
| EPS Growth | ★ 20.42 | N/A |
| EPS | 2.21 | ★ 2.35 |
| Revenue | ★ $364,494,000.00 | $151,176,000.00 |
| Revenue This Year | N/A | $7.08 |
| Revenue Next Year | $3.33 | $3.69 |
| P/E Ratio | ★ $6.98 | $8.24 |
| Revenue Growth | N/A | ★ 4.25 |
| 52 Week Low | $13.14 | $16.70 |
| 52 Week High | $19.78 | $23.55 |
| Indicator | INMD | FDUS |
|---|---|---|
| Relative Strength Index (RSI) | 57.72 | 49.28 |
| Support Level | $13.89 | $19.13 |
| Resistance Level | $15.90 | $19.97 |
| Average True Range (ATR) | 0.44 | 0.35 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 61.84 | 42.41 |
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Fidus Investment Corp is an externally managed, closed-end, non-diversified management investment company that has elected to be treated as a business development company. The company provides customized debt and equity financing solutions to lower middle-market companies. Its investment objective is to provide attractive risk-adjusted returns by generating both current income from debt investments and capital appreciation from equity related investments. The company's portfolio of investments is comprised of securities of companies from different industries such as, Information Technology Services, Business Services, Healthcare Products among others.